The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block (NCT04876989) | Clinical Trial Compass
CompletedNot Applicable
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block
South Korea69 participantsStarted 2021-07-21
Plain-language summary
The purpose of this study is to investigate the effect of ultrasound-guided thoracic paravertebral block (TPVB) when performing sympathetic block for upper limb pain control.
Who can participate
Age range19 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Clinical diagnosis of complex regional pain syndrome
* Clinical diagnosis of postherpetic neuralgia
* Clinical diagnosis of phantom limb pain
* Clinical diagnosis of chronic post-surgical pain
* Clinical diagnosis of post-traumatic pain syndrome
* Upper extremity pain lasting more than 3 months
Patients with a new or known diagnosis of chronic neuropathic pain lasting more than 3 months in the upper extremity
Exclusion Criteria:
* Refusal of a patient
* Any vascular disease in the upper extremities
* Previous history of thoracic sympathetic or stellate ganglion neurolysis (e.g. -thermocoagulation, radiofrequency neuromodulation, and/or chemical neurolysis)
* Coagulopathy
* Systemic infection or local infection at the needle injection site
* Major deformation at the level of the neck (radiotherapy, surgery, etc.)
* Known allergy to local anesthetics of amide type
* Inability to understand a numeric rating pain scale (cognitive dysfunction)
* Patients whose palm temperature on the ipsilateral side is ≥ 36.5℃ in the thermography before the procedure
What they're measuring
1
Proportion of patients reaching > 1.5°C rise of temperature in the ipsilateral hand compared to the contralateral hand
Timeframe: 20 minutes after US-guided thoracic paravertebral block or US-guided stellate ganglion block